Trust Guidelines and Policies on the Management of sickle cell disease and thalassaemia
On this page:
ACUTE MANAGEMENT
SGH_HN506a_guidelines Acute complications of SCD
SGH_HN506b_guidelines Acute complications of thalassaemia
SGH guidelines Spirometry in sickle cell crisis Feb 2019
ED Guideline Management of Acute Sickle Cell Crisis
SPECIALIST MANAGEMENT
SGH guidelines Perioperativemanagement Feb 2019
OUTPATIENT AND MONITORING
SGH_HN502a_guidelines Outpatient monitoring SCD and thalassaemia
SGH_HN508a_guidelines Chronic complications of SCD- Renal Disease
SGH_HN508b_guidelines Chronic complications of SCD – Othopaedic AVN
SGH_HN508c_guidelines Chronic complications of SCD – Ophthalmology
SGH_HN508d_guidelines Chronic complications of SCD – Cardiac and Respiratory
SGH_HN508f_guidelines Chronic complications of SCD – Endocrine and Rheumatology
SGH_HN508g_guidelines Chronic complications of SCD – Neurological
SGH_HN508h_guidelines Chronic complications of SCD – Chronic Pain
SGH_HN508i_guidelines Chronic complications of SCD – Liver disease
SGH_HN508x_guidelines Chronic complications of SCD – Urology
BLOOD TRANSFUSION IN HAEMOGLOBINOPATHIES
Blood transfusion in patients with Sickle Cell Disease
Blood transfusion in patients with Thalassaemia
Emergency Manual Exchange Transfusion for patients with Sickle Cell Disease
Iron overload in patients with Sickle Cell Disease
Iron overload in patients with Thalassaemia
Management of hyperhaemolysis in patients with Haemoglobinopathies
SGH Adult Blood Tranfusion Policy
